"CORONAVIRUS INFO: Appointment days and times at this location may currently be modified. Penn Medicine Lancaster General Health is dedicated to the health and safety of patients, their families, and our staff. Check our website for updated hours."

During the past decade, Heart Group conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Heart Group" #1 collaborator was "Duke Clinical Research Institute" with 1 trials as a collaborator, "Orion Corporation, Orion Pharma" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Heart Group" are "Acute Coronary Syndromes" (1 trials) and "Heart Failure, Congestive" (1 trials). Many other conditions were trialed in "Heart Group" in a lesser frequency.

Most popular intervention types in "Heart Group" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Acetylsalicylic acid" (1 trials), "Acetylsalicylic acid placebo" (1 trials), "Apixaban" (1 trials), "Levosimendan" (1 trials) and "vitamin K antagonist" (1 trials). Other intervention names were less common.

The vast majority of trials in "Heart Group" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Heart Group". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Heart Group, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Heart Group, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".